Prof. Dr. Ziv J. Haskal’s research has spanned the breadth of IR, beginning with defining early research in TIPS and complex portal hypertension; his preclinical experimental and human studies led to creation of the TIPS endograft used by the majority of the world. His research has included preclinical validation and in-human interventional trans-arterial gene vector; the first demonstration of IR radiation eye injury risks at occupational levels; trials in accelerated pharmacomechanical deep vein interventions; advances in hemodialysis access care, including the first randomized trials of dialysis stent grafts that defined the first proven superior intervention for AV graft stenosis, benefiting thousands worldwide; liver transplant interventions; all aspects of embolization; and interventional oncology. He has published over 400 manuscripts, abstracts, chapters, books, letters, and editorials in journals such as the New England Journal of Medicine, Human Gene Therapy, Circulation, Hepatology, Radiology, CVIR, AJR, and JVIR. His papers have been cited thousands of times – the AHA/ACC PAD Guideline he co-chaired and co-wrote, alone, has been cited over 5300 times. His H-index is >60. Prof. Haskal has led or participated in over 50 human and animal research studies. He has consulted extensively for decades, and continues to, for startups to large companies, from strategy, device design, to trial creation and conduct. He has led multiple PMAs, resulting in devices that are in use in over 80% of the planet.

Prof. Haskal has given more than 700 invited lectures worldwide and been awarded numerous honorary fellowships, named lectures, and received multiple of the highest national and international societal awards for innovation, leadership, service, career and research excellence, gold medals, honorary fellowships, and served in many societal leadership, presidency, and committee roles. Dr. Haskal served as the deputy editor-in-chief of CVIR for five years and doubled its Impact Factor. Thereafter, he served two terms as the JVIR editor-in-chief (10 years) during which he nearly tripled its submissions, raised the impact factor to 3.037 and launched its multimedia, social media feeds, blog, editorial fellowship, podcasts, IR virtual reality, and other new topics and features. In those editor roles, he line-edited over 18,000 manuscripts. He has founded, led or designed many national and international scientific congresses, most recently the new SIR EDGE meeting. In nearly 30 years, Prof. Haskal has mentored hundreds of trainee;s hid ‘Editor’s Writing Club’ seminars have reached over 1000 attendees worldwide.